small-cell lung cancerTumor lysis syndrome is a rare complication of nonhematologic malignancies that results from massive necrosis of neoplastic cells after chemotherapy. This syndrome consists of life-threatening metabolic derangements, including severe hyperphosphatemia, hyperkalemia, hyperuricemia, and ...
在初步诊断为广泛期SCLC时,18%的患者有脑转移且2年后增至约80%。EORTC(European Organization for Research and Treatment of Cancer)的一项研究,将对化疗有反应的患者随机化分为2组,接受PCI或不接受PCI,发现PCI治疗组1年生存率为27.1%,未接受PCI者为13.3%。[49]在该研究中,PCI不仅减少脑转移的发生率也提高无...
Forde, Patrick M.Chatterjee, SouvikHann, Christine L.Elsevier Inc.Journal of Thoracic OncologyBoikos SA, Forde PM, Chatterjee S, Hann CL. Tumor lysis syndrome in limited-stage small-cell lung cancer . J Thorac Oncol . 2013; 8 :e61–2 [ PubMed ]...
We report a case of tumor lysis syndrome after induction chemotherapy in a patient with widely metastatic smallcell lung cancer. This case emphasizes the importance of awareness and early treatment of this syndrome. 展开 关键词: tumor lysis syndrome chemotherapy small-cell lung cancer ...
类器官Small Cell Lung Cancer 类器官(Organoids)是指将成体干细胞或多能干细胞在体外三维培养形成的具有一定空间结构的组织类似物。类器官在组织结构、细胞类型、自我更新能力和功能等方面与来源组织高度一致,从而在发育生物学、疾病造模、精准医学、药物研发、基因和细胞疗法、感染和免疫以及再生医学等生物医学的多个领...
Institute of Cell and Tumor Biology, German Cancer Research Center, Im Neuenheimer Feld 280, D-6900 Heidelberg. J Histochem Cytochem 1990;38:1313-21 Lung Cancer, Volume 7, Issue 3, June 1991, Pages 190 PDF (171 K) Tumor Lysis Syndrome: New Challenges and Recent Advances 2014, Advances ...
Human small-cell lung-cancer cells are cytokine-resistant but NK/LAK-sensitiveHumansKiller Cells, Lymphokine-ActivatedTumor Cells, CulturedCarcinoma, Small CellLung NeoplasmsRNA, NeoplasmRecombinant ProteinsInterferon-gamma, RecombinantBlotting, Northern...
Non-small cell lung cancer (NSCLC) remains an ongoing health concern, with poor treatment options and prognosis for many patients. Typically, individuals with lung cancer are detected at the middle and terminal stages, resulting in poor medical results d
Non-small cell lung cancer (NSCLC) remains an ongoing health concern, with poor treatment options and prognosis for many patients. Typically, individuals with lung cancer are detected at the middle and terminal stages, resulting in poor medical results d
Hyponatremia is the most common electrolyte disorder in clinical practice.It is also one of the clinical manifestations associated with small cell lung cancer(SCLC).When the tumor is accompanied by hyponatremia,the pathogenesis of SCLC is mainly related to the syndrome of abnormal secretion of antidiu...